Gleave ME - Search Results

1

[In vitro and in vivo models developed from human prostatic cancer].

Bladou F, Gleave ME, Penault-Llorca F, Serment G, Lange PH, Vessella RL. Bladou F, et al. Among authors: gleave me. Prog Urol. 1997 Jun;7(3):384-96. Prog Urol. 1997. PMID: 9273065 Review. French.

2

Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Andrieu C, Taieb D, Baylot V, Ettinger S, Soubeyran P, De-Thonel A, Nelson C, Garrido C, So A, Fazli L, Bladou F, Gleave M, Iovanna JL, Rocchi P. Andrieu C, et al. Oncogene. 2010 Apr 1;29(13):1883-96. doi: 10.1038/onc.2009.479. Epub 2010 Jan 18. Oncogene. 2010. PMID: 20101233

3

Intermittent androgen suppression delays progression to androgen-independent regulation of prostate-specific antigen gene in the LNCaP prostate tumour model.

Sato N, Gleave ME, Bruchovsky N, Rennie PS, Goldenberg SL, Lange PH, Sullivan LD. Sato N, et al. Among authors: gleave me. J Steroid Biochem Mol Biol. 1996 May;58(2):139-46. doi: 10.1016/0960-0760(96)00018-0. J Steroid Biochem Mol Biol. 1996. PMID: 8809195

4

Androgenic induction of prostate-specific antigen gene is repressed by protein-protein interaction between the androgen receptor and AP-1/c-Jun in the human prostate cancer cell line LNCaP.

Sato N, Sadar MD, Bruchovsky N, Saatcioglu F, Rennie PS, Sato S, Lange PH, Gleave ME. Sato N, et al. Among authors: gleave me. J Biol Chem. 1997 Jul 11;272(28):17485-94. doi: 10.1074/jbc.272.28.17485. J Biol Chem. 1997. PMID: 9211894 Free article.

5

Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis.

Rocchi P, Beraldi E, Ettinger S, Fazli L, Vessella RL, Nelson C, Gleave M. Rocchi P, et al. Cancer Res. 2005 Dec 1;65(23):11083-93. doi: 10.1158/0008-5472.CAN-05-1840. Cancer Res. 2005. PMID: 16322258

6

Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance.

Tanaka H, Kono E, Tran CP, Miyazaki H, Yamashiro J, Shimomura T, Fazli L, Wada R, Huang J, Vessella RL, An J, Horvath S, Gleave M, Rettig MB, Wainberg ZA, Reiter RE. Tanaka H, et al. Nat Med. 2010 Dec;16(12):1414-20. doi: 10.1038/nm.2236. Epub 2010 Nov 7. Nat Med. 2010. PMID: 21057494 Free PMC article.

7

[Hormone release and intermittent hormonal therapy in the LN CaP model of human prostate cancer].

Gleave M, Santo N, Rennie PS, Goldenberg SL, Bruchovsky N, Sullivan LD. Gleave M, et al. Prog Urol. 1996 Jun;6(3):375-85. Prog Urol. 1996. PMID: 8763692 French.

8

Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells.

Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S, Chung LW. Wu HC, et al. Among authors: gleave me. Int J Cancer. 1994 May 1;57(3):406-12. doi: 10.1002/ijc.2910570319. Int J Cancer. 1994. PMID: 8169003

9

Menin inhibition suppresses castration-resistant prostate cancer and enhances chemosensitivity.

Cherif C, Nguyen DT, Paris C, Le TK, Sefiane T, Carbuccia N, Finetti P, Chaffanet M, Kaoutari AE, Vernerey J, Fazli L, Gleave M, Manai M, Barthélémy P, Birnbaum D, Bertucci F, Taïeb D, Rocchi P. Cherif C, et al. Oncogene. 2022 Jan;41(1):125-137. doi: 10.1038/s41388-021-02039-2. Epub 2021 Oct 28. Oncogene. 2022. PMID: 34711954 Free PMC article.

10

Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts.

Gleave M, Hsieh JT, Gao CA, von Eschenbach AC, Chung LW. Gleave M, et al. Cancer Res. 1991 Jul 15;51(14):3753-61. Cancer Res. 1991. PMID: 1712249

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters